Speakers

Top Speakers Across 5 Co-Located Conferences

Plenary Speakers

Senior Representative from Fosun Pharma

Richard Wang
CEO, Fosun Kite Biotech, China

He Ting
Chief Executive Officer, ImmunoChina, China

Dong Wei
CEO, Edigene, China

Zonghai Li
President and Chief Executive Officer, CARsgen Therapeutics, China

Peter Luo
CEO, Adagene Pharma, China

Ruirong Yuan
President, Chief Medical Officer and Board Director, Adlai Nortye Biopharma, China

Eddy Wu
China Head/Vice-President, Terns Pharmaceutical, China

Jonathan Zhao
PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China

Zhou Mingdong
CEO and Chief Scientist, Zensun, China

Zhengyu Yuan
President & Chief Executive Officer, MicuRx Pharmaceuticals Inc., China

10th Annual BioSimilars Asia Speakers

Dr. Scott Liu
President and CEO, Shanghai Henlius Biotech Inc., China

Dr Wu Youling
Chief Executive Officer, ZheJiang Teruisi Biopharmaceutical, China

Lin Jian
Vice President of Regulatory Affairs, Bio-Thera Solutions, China

Senior Representative, Innovent Biologics

Dr. Manfred Weiler
Senior Vice President, Medical & Scientific Strategy, Syneos Health, UK

Jim Cucinotta
Senior Director, Global Clinical Operations, Oncology/Hematology & Biosimilars, Head of Clinical Supply Chain, Teva Pharmaceuticals, USA

Dr Lin Shiwen
Vice President of Downstream Process Development, WuXi Biologics, China

Senior Representative, Innovent Biologics

Hark Chen
Vice President, Process Development, Mycenax Biotech Inc, Taiwan

Ou Huilan
Director of Regulatory Affairs, Shanghai Henlius Biotech, China

Wang Yongzhong
President of Pharmaceuticals, Executive Vice President, Simcere Pharmaceutical Group, China

Sumimasa Nagai
Deputy Director of the Translational Research Centre / Clinical Expert Advisor at the Office of New Drug V (Oncology) and Companion Diagnostics Working Group, University of Tokyo Hospital / Pharmaceuticals and Medical Devices Agency, Japan

Dr Abhay Sinha
Regional Director, Pharmaceuticals Export Promotion Council of India, India

Dr. Allen Ho
Head of Regulatory Affairs CMC, JHL Biotech Inc.

Brian Hosung Min
Senior Vice President, Samsung Bioepis, South Korea

Dr Jiang Weidong
Vice President and Chief Scientific Officer, Shanghai Henlius Biotech, China

9th Annual Biomanufacturing Speakers

Dr Junli Zhang
Senior Vice President of Global Manufacturing and Technical Operation, Shanghai Henlius Biotech, Inc.

Racho Jordanov
Co-founder, Co-Chairman, President and Chief Executive Officer, JHL Biotech, China

Jian Dong
VP & Site Head of Manufacturing, Wuxi AppTec, China

Dr. Xiangyang Zhu
Chief Executive Officer, Huabo Biopharma, China

Jason Lukasek
Senior Director, BEA, BPD Commercial, Thermo Fisher Scientific

Jerry Yang
Senior Vice President, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd. China

Senior Representative from PALL

Xu Wei
Vice President, Manufacturing, Innovent Biologics, China

Dr Wu Youling
Chief Executive Officer, ZheJiang Teruisi Biopharmaceutical, China

Shou Bai Chao
Senior Vice President, Bio Venture AstraZeneca China

Dr. Qinghai Zhao
Vice President, Technical Development & Manufacturing, Forty Seven, Inc., U.S.

Dr Jerry Dong
Vice President of CMC and Regulatory Affairs, Shanghai Henlius Biotech, Inc.

Dr. Lin Yang
Chief Executive Officer, PersonGen Biomedicine, China

8th Annual Cell Line Development and Engineering Asia Speakers

George Hutchinson
Head of Global Distribution, Solentim, UK

Thomas Kelly
Scientist, Cell & Developability Sciences, Pharmaceutical Development & Manufacturing Sciences (PDMS), Janssen R&D, U.S.

Dr. John Yan
Applications Scientist, ProZyme, U.S.

James (Jianguo) Yang
Chief Executive Officer, Tayu Huaxia Biotech Medical Group, China

Dr. Carolanne Doherty
Marketing & Sales Manager, Valitacell, Ireland

Dr. Ben Borgo
Associate Director, Assays, Reagents, and Software, Berkeley Lights, U.S.

Jerry Yang
SVP, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd., China

Dr. Qinghai Zhao
Vice President, Technical Development & Manufacturing, Forty Seven, Inc., U.S.

Cuiyun Xu
Director, Upstream Process Development, Shanghai Henlius Biotech, Inc., China

Eric Chang
Head of Cell Line Development, JHL Biotech, Taiwan

Dr. Jianwei Zhu
Chair Professor and Dean of School of Pharmacy, Shanghai Jiao Tong University (SJTU); Director of MOE Engineering Research Center of Cell Engineering and Antibody; President and Chief Executive Officer, Jecho Biopharmaceuticals, China

Minmin Qin
Senior Vice President and Head, CMC, Harbour BioMed, China

Dr. Steve Oh
Institute Scientist and Director, Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR, Singapore

Jing Liao
Senior Scientist, LogicBio Therapeutics, U.S.

Weon-Kyoo You
Vice President and Head, R&D, ABL Bio, Inc., South Korea

Dong-Yup Lee
Associate Professor, College of Engineering, Sung Kyun Kwan University (SKKU), South Korea

Dr. John E. Gil IV
Director, Head of Cell Line Generation, Shire HGT, U.S

Dr. Senyon Choe (Teddy)
Professor, Biology, University of California San Diego (UCSD), U.S. and President and Director of Joint Center for Biosciences, South Korea

4th Annual Clinical Trials Speakers

Dr. Xin Zhang
Vice President of Global Clinical Operations and Affairs, Shanghai Henlius Biotech, Inc., China

Audrey Jia
Former FDA CMC Biologic Reviewer, U.S.

Senior Representative, Innovent Biologics

Don Van Dyke
Chief Operating Officer, Cloud Pharmaceuticals, USA

Dr. Alvin Luk
Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Joanne Chio
Head, Clinical Trials – Healthcare Services, National University Hospital Singapore, Singapore

Hei Yongjiang
Chief Medical Officer, Oncology, Zai Laboratory, China

James Cheng-Chung Wei
Professor, Institute of Medicine, Chief, Division of Allergy, Immunology and Rheumatology, Director, Chinese Medicine Clinical Trial Center, Chung Shan Medical University Hospital, Taiwan

Chen Chien Shing
Executive Director, Cancer Center, Shanghai Jiahui International Hospital and Clinics, China

Liu Baorui
Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, China

Dr Jean-Louis Excler
Head of Clinical Development & Regulatory, International Vaccine Institute, Korea

Jennifer Harmon
Director, Clinical Affairs, SynAgile, Singapore

Rong Chen
Chief Medical Officer, JHL Biotech, China

Cell and Gene Therapy Speakers

Zonghai Li
President and Chief Executive Officer, CARsgen Therapeutics, China

Peter Luo
CEO, Adagene Pharma, China

Ruirong Yuan
President, Chief Medical Officer and Board Director, Adlai Nortye Biopharma, China

Eddy Wu
China Head/Vice-President, Terns Pharmaceutical, China

Jonathan Zhao
PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China

Zhou Mingdong
CEO and Chief Scientist, Zensun, China

Dody Bautista
Chief Scientist, Sibiono GeneTech, China

Judith Li
Partner, Lilly Asia Ventures, Hong Kong

Bosun Hau
Head of Global Healthcare and Investment / Independent Director, Sailing Capital Advisors / Cellular Biomedicine Group, Hong Kong

Lynn Yang
Managing Director, Sequoia Capital, China

Chelsea Zhang
Partner, Ping An Ventures, China

Senior Representative, PALL® Biotech

Daniel Takefman
Head of Regulatory Affairs, Spark Therapeutics, United States

Jiansong Tong
Director and Head of CAR-T Cell Therapy, Shanghai Hengrui Pharmaceutical, China

Sumimasa Nagai
Deputy Director of the Translational Research Centre / Clinical Expert Advisor at the Office of New Drug V (Oncology) and Companion Diagnostics Working Group, University of Tokyo Hospital / Pharmaceuticals and Medical Devices Agency, Japan

Paolo Morgese
Director for EU Market Access and Member Relations, Alliance for Regenerative Medicine, Switzerland

Ryan Chang
Chief Executive Officer, Steminent Biotherapeutics, Taiwan

Rohit Kulkarni
Vice-President / Director, Stem Cell Society of India / Reelabs, India

Steve Oh
Institute Professor and Scientist at the Bioprocessing Technology Institute, A-STAR, Singapore

Sandy Qlintang
Deputy Director of Stem Cell and Cancer Institute, PT Kalbe Farma, Indonesia

Chen-Yuan Lin
Ward Director and Attending Physician at the Division of Hematology and Oncology, China Medical University Hospital, Taiwan

David Bekkers
Officer for Innovation, Technology & Science, Holland Innovation Network in China, Netherlands

Morakot Papassiripan
Pharmacist at the Professional Level at the Biological Sub-Division, Bureau of Drug Control, Food and Drug Administration of Thailand, Thailand

Pre-Conference Workshop Speakers

Xiaodi Su
Senior Investment Manager, Lilly Asia Ventures, China

Jieyu Zou
Vice President, Lilly Asia Ventures, China